Kenneth L. McClain, MD, PhD
- Cancer and Blood Disorders
Director, Histiocytosis Program
Director, Pediatric Lymphoma-Histiocytosis Fellowship Program
Professor, Department of Pediatrics, Division of Hematology-Oncology, Baylor College of Medicine
Office location:
Texas Medical Center
6701 Fannin Street
Houston, TX 77030
Get to know Kenneth L. McClain, MD, PhD
Dr. Kenneth McClain is Director of the Histiocytosis Program at Texas Children’s Cancer and Hematology Center and a member of the leukemia and lymphoma programs. Dr. McClain and Dr. Carl Allen see 150 newly-diagnosed patients with a variety of histiocytic diseases each year and follow more than 1,000 active patients, including patients from five continents.
Intereses Clinicos
His clinical interests include: hematologic disorders, leukemia, lymphoma, histiocytosis, and sickle cell disease.
Educacion
| School | Education | Degree | Year |
|---|---|---|---|
| University of Minnesota Medical School at Minneapolis | Fellowship | Hematology-Oncology | 1981 |
| National Institutes of Health | Fellowship | Molecular & Human Genetics | 1979 |
| Johns Hopkins University School of Medicine | Residency | Pediatrics | 1976 |
| Johns Hopkins University School of Medicine | Internship | Pediatrics | 1974 |
| University of Chicago, Pritzker School of Medicine | Medical School | Doctor of Medicine | 1973 |
| University of Chicago, Pritzker School of Medicine | PhD | Doctor of Philosophy | 1972 |
Organizaciones
| Nombre de la Organizacion | Rol |
|---|---|
| American Society of Hematology (ASH) | Member |
| American Society of Pediatric Hematology/Oncology (ASPHO) | Member |
| Current Reviews in Pediatrics | Editorial Board, 2004-Present |
| Gulf Coast Hematology Society (GCHS) | Past-President |
| Histiocyte Society | Past-President |
| Histiocytosis Association of America (HAA) | Board Member |
| PDQ Pediatric Treatment Editorial Board | 2006 - Present |
| Society for Pediatric Research | Member, 1986-Present |
Board Certifications
American Board of Pediatrics - Pediatrics
American Board of Pediatrics - Pediatric Hematology/Oncology
Honors and awards
- 2019
-
George R. Buchanan Lectureship Award
American Society of Pediatric Hematology/Oncology - 2009
-
Who's Who
- 2005-2009
-
Texas Super Doctor
- 2003-2009
-
Best Doctor
- 2007
-
Nesbit Prize for Best Clinical Paper
23rd Annual Histiocyte Society Meeting, Cambridge England - 2005-2006
-
Texas Super Doctor
- 2004
-
Montclair Who’s Who in Healthcare
- 2003-2008
-
Best Doctors in America
- 2002
-
Visiting Professor of Pediatrics
McGill University - 2002
-
Ph.D. Thesis Opponent
The Karolinska Institute, Stockholm Sweden - 2000-2003
-
President
Histiocyte Society - 2000
-
Who’s Who
- 1996
-
Visiting Professor of Pediatrics
Charles University, Second Medical Faculty, Motol, Prague, Czech Republic, Conferred - 1998-2001
-
Editorial Board
Medical and Pediatric Oncology -
AcademicKeys Who’s Who in Medical Sciences
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Highlights
Paving the way to better diagnosis and treatment for Langerhans cell histiocytosis
BCM.edu
Area de investigacion:
Histiocytosis
Dr. Kenneth McClain's research is focused on the clinical and biologic aspects of Langerhans cell histiocytosis (LCH). He is a key member of the clinical trials group of the Histiocyte Society. A number of clinical studies are in progress or development including new therapeutic interventions for CNS LCH. Current biologic studies in his lab are focused on determining the gene expression profiles Langerhans cells and lymphocytes from control and patient tissues and making clinical correlations.
Research interests
Clinical and biologic aspects of Langerhans cell histiocytosis (LCH), Gene expression profiles